Radformation and Icon Group have forged a transformative partnership to redefine cancer care through cutting-edge software solutions and streamlined workflows. This collaboration combines Radformation’s expertise in radiation oncology software with Icon Group’s global leadership…
Continue Reading
The partnership between ACRO, ACR, ASTRO, and ASCO signifies a pivotal effort to address the critical challenges posed by Medicare payment cuts in radiation oncology. As leaders in the field, these organizations pool their…
Continue Reading
The Anticipated Acquisition Aligns to GE HealthCare’s Precision Care Strategy with the Goal of Strengthening the Company’s Digital Solutions Across Care Pathways
MIM Software Provides AI-Enabled Image Analysis and Workflow Tools Across Multiple Care Areas,…
Artificial General Intelligence (AGI) is reshaping radiation oncology, boosting precision and efficiency. AGI models like GPT-4, PaLM 2, and LVMs such as SAM excel in auto-segmentation, treatment planning, and outcome prediction. Their few-shot and…
Continue Reading
Researchers at the Wyss Institute at Harvard University have developed a microfluidic chip that can recreate some of the features of radiation-induced lung injury. The lungs are very sensitive to radiation, and this can…
Continue Reading
By Sara Heath
October 11, 2023 – New data in the journal Radiation Oncology is providing more insights into how the 21st Century Cures Act’s provision mandating immediate patient data access and access to lab results…
Continue Reading
New research conducted by radiation oncology physicists at Miami Cancer Institute reveals remarkable precision in intracranial stereotactic radiosurgery (SRS) using an MR-guided radiotherapy system, the ViewRay MRIdian. Published in the International Journal of Radiation…
Continue Reading
Mevion Medical Systems and RaySearch Laboratories are collaborating to pioneer groundbreaking solutions in proton therapy. Their partnership focuses on enhancing treatment planning, supporting adaptive therapy, advancing proton arc therapy, and facilitating FLASH proton therapy….
Continue Reading
A groundbreaking study reveals the effectiveness of liquid biopsy tests in guiding personalized treatment for non-small cell lung cancer (NSCLC) patients. Unlike conventional methods, these tests focus on circulating tumor DNA (ctDNA) levels, providing…
Continue Reading
RefleXion Medical is set to unveil its game-changing RefleXion X1 with SCINTIX biology-guided radiotherapy at the ASTRO 2023 Annual Meeting in San Diego, BOOTH #2831. A robust lineup of 19 scientific presentations by researchers…
Continue Reading
